Monitoring serum beta-2 microglobulin is useful for detecting patients with increased risk of acute rejection during reduction in immunosuppression

Transplant Proc. 1998 Dec;30(8):4158-9. doi: 10.1016/s0041-1345(98)01378-5.

Authors

N O Câmara¹, S Nishida, M S Silva, J O Pestana, A B Pereira, R Sesso, A Pacheco-Silva

Affiliation

¹ Department of Medicine, Federal University of São Paulo, Brazil.

PMID: 9865333
DOI: 10.1016/s0041-1345(98)01378-5

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Analysis of Variance
Confidence Intervals
Creatinine / blood
Enzyme-Linked Immunosorbent Assay
Female
Graft Rejection / blood
Graft Rejection / prevention & control*
Humans
Immunosuppression Therapy / methods*
Kidney Transplantation / immunology*
Kidney Transplantation / physiology
Male
Monitoring, Physiologic
Odds Ratio
Regression Analysis
Risk Assessment
Risk Factors
beta 2-Microglobulin / analysis*

Substances

beta 2-Microglobulin
Creatinine